The Inclusion of Timolol and Lisinopril in Calcium Phosphate Particles Covered by Chitosan: Application in Ophthalmology
- 作者: Nikolskaya I.I.1, Beznos O.V.2, Eltsov A.I.1, Gachok I.V.1, Chesnokova N.B.2, Varlamov V.P.3, Kost O.A.1
-
隶属关系:
- Department of Chemistry
- Helmholtz Moscow Research Institute of Eye Diseases
- Federal Research Center “Fundamentals of Biotechnology,”
- 期: 卷 73, 编号 2 (2018)
- 页面: 85-89
- 栏目: Article
- URL: https://bakhtiniada.ru/0027-1314/article/view/163638
- DOI: https://doi.org/10.3103/S0027131418020116
- ID: 163638
如何引用文章
详细
Chitosan-covered calcium phosphate nanoparticles with the mean dynamic radii of 30 to 130 nm and ζ-potential of +22 ± 4 mV containing timolol and lisinopril are prepared and characterized. These particles are formed by the amorphous phase represented by amorphous calcium phosphate Cax(PO4)y · zH2O and the crystalline phase represented by hydrated calcium hydrophoshate (brushite) CaHPO4 · 2H2O. The experiments in vivo demonstrated that the inclusion of timolol into calcium phosphate particles covered with chitosan substantially prolonged its effect on the intraocular pressure.
作者简介
I. Nikolskaya
Department of Chemistry
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 119991
O. Beznos
Helmholtz Moscow Research Institute of Eye Diseases
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 105062
A. Eltsov
Department of Chemistry
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 119991
I. Gachok
Department of Chemistry
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 119991
N. Chesnokova
Helmholtz Moscow Research Institute of Eye Diseases
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 105062
V. Varlamov
Federal Research Center “Fundamentals of Biotechnology,”
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 119071
O. Kost
Department of Chemistry
编辑信件的主要联系方式.
Email: olga.a.kost@gmail.com
俄罗斯联邦, Moscow, 119991
补充文件
